180 related articles for article (PubMed ID: 11823078)
1. Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine.
Fragasso G; Piatti PM; Monti L; Palloshi A; Lu C; Valsecchi G; Setola E; Calori G; Pozza G; Margonato A; Chierchia S
J Am Coll Cardiol; 2002 Feb; 39(3):413-9. PubMed ID: 11823078
[TBL] [Abstract][Full Text] [Related]
2. Detrimental effects of acute heparin administration on ischemic threshold in patients with coronary artery disease.
Fragasso G; Leonardo F; Piatti P; Monti LD; Sheiban I; Gernone F; Setola E; Pontiroli AE; Chierchia SL
Ital Heart J; 2000 Jun; 1(6):407-11. PubMed ID: 10929741
[TBL] [Abstract][Full Text] [Related]
3. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
Topal E; Ozdemir R; Barutcu I; Aksoy Y; Sincer I; Akturk E; Cehreli S
J Electrocardiol; 2006 Apr; 39(2):211-8. PubMed ID: 16580422
[TBL] [Abstract][Full Text] [Related]
4. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
Marazzi G; Wajngarten M; Vitale C; Patrizi R; Pelliccia F; Gebara O; Pierri H; Ramires JA; Volterrani M; Fini M; Rosano GM
Int J Cardiol; 2007 Aug; 120(1):79-84. PubMed ID: 17134770
[TBL] [Abstract][Full Text] [Related]
5. The anti-ischemic effect of trimetazidine in patients with postprandial myocardial ischemia is unrelated to meal composition.
Fragasso G; Montano C; Perseghin G; Palloshi A; Calori G; Lattuada G; Oggionni S; Bassanelli G; Locatelli M; Lopaschuk G; Margonato A
Am Heart J; 2006 Jun; 151(6):1238.e1-8. PubMed ID: 16781225
[TBL] [Abstract][Full Text] [Related]
6. Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study.
Chazov EI; Lepakchin VK; Zharova EA; Fitilev SB; Levin AM; Rumiantzeva EG; Fitileva TB
Am J Ther; 2005; 12(1):35-42. PubMed ID: 15662290
[TBL] [Abstract][Full Text] [Related]
7. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
[TBL] [Abstract][Full Text] [Related]
8. Effects of trimetazidine on submaximal exercise test in patients with acute myocardial infarction.
Güler N; Eryonucu B; Günes A; Güntekin U; Tuncer M; Ozbek H
Cardiovasc Drugs Ther; 2003 Jul; 17(4):371-4. PubMed ID: 14696632
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
Fragasso G; Piatti Md PM; Monti L; Palloshi A; Setola E; Puccetti P; Calori G; Lopaschuk GD; Margonato A
Am Heart J; 2003 Nov; 146(5):E18. PubMed ID: 14597947
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina--the VASCO-angina study.
Vitale C; Spoletini I; Malorni W; Perrone-Filardi P; Volterrani M; Rosano GM
Int J Cardiol; 2013 Sep; 168(2):1078-81. PubMed ID: 23200272
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
[TBL] [Abstract][Full Text] [Related]
12. Trimetazidine improves exercise performance in patients with peripheral arterial disease.
Vitale C; Marazzi G; Pelliccia F; Volterrani M; Cerquetani E; Spoletini I; Mercuro G; Bonassi S; Dall'Armi V; Fini M; Rosano GM
Pharmacol Res; 2011 Apr; 63(4):278-83. PubMed ID: 21220024
[TBL] [Abstract][Full Text] [Related]
13. Effects of metabolic approach in diabetic patients with coronary artery disease.
Fragasso G; Salerno A; Spoladore R; Cera M; Montanaro C; Margonato A
Curr Pharm Des; 2009; 15(8):857-62. PubMed ID: 19275650
[TBL] [Abstract][Full Text] [Related]
14. Effects of trimetazidine in nonischemic heart failure: a randomized study.
Winter JL; Castro PF; Quintana JC; Altamirano R; Enriquez A; Verdejo HE; Jalil JE; Mellado R; Concepción R; Sepúlveda P; Rossel V; Sepúlveda L; Chiong M; García L; Lavandero S
J Card Fail; 2014 Mar; 20(3):149-54. PubMed ID: 24412523
[TBL] [Abstract][Full Text] [Related]
15. Effect of trimetazidine on exercise performance in patients with coronary artery ectasia.
Dogan A; Ozaydin M; Gedikli O; Altinbas A; Ergene O
Jpn Heart J; 2003 Jul; 44(4):463-70. PubMed ID: 12906028
[TBL] [Abstract][Full Text] [Related]
16. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
Rosano GM; Vitale C; Fragasso G
Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
[TBL] [Abstract][Full Text] [Related]
17. Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease.
Costa LMA; Rezende PC; Garcia RMR; Uchida AH; Seguro LFBC; Scudeler TL; Bocchi EA; Krieger JE; Hueb W; Ramires JAF; Filho RK
Medicine (Baltimore); 2015 Aug; 94(33):e1161. PubMed ID: 26287407
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials.
Marzilli M; Klein WW
Coron Artery Dis; 2003 Apr; 14(2):171-9. PubMed ID: 12655281
[TBL] [Abstract][Full Text] [Related]
19. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
Sellier P; Broustet JP
Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
[TBL] [Abstract][Full Text] [Related]
20. Trimetazidine offers myocardial protection in elderly coronary artery disease patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial.
Dai ZL; Song YF; Tian Y; Li Y; Lin M; Lin J; Wang Q; Wang P; Gao WL
BMC Cardiovasc Disord; 2021 Oct; 21(1):473. PubMed ID: 34598676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
